A detailed history of Parkside Financial Bank & Trust transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 2,640 shares of GILD stock, worth $232,531. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,640
Previous 3,268 19.22%
Holding current value
$232,531
Previous $239,000 24.27%
% of portfolio
0.03%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$63.15 - $72.88 $39,658 - $45,768
-628 Reduced 19.22%
2,640 $181,000
Q1 2024

May 01, 2024

BUY
$71.58 - $87.29 $14,673 - $17,894
205 Added 6.69%
3,268 $239,000
Q4 2023

Feb 01, 2024

BUY
$73.27 - $83.09 $12,089 - $13,709
165 Added 5.69%
3,063 $248,000
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $14,640 - $15,972
198 Added 7.33%
2,898 $217,000
Q2 2023

Aug 15, 2023

BUY
$76.01 - $86.7 $58,831 - $67,105
774 Added 40.19%
2,700 $208,000
Q1 2023

May 04, 2023

BUY
$77.31 - $88.08 $7,808 - $8,896
101 Added 5.53%
1,926 $159,000
Q4 2022

Feb 13, 2023

BUY
$62.32 - $89.47 $8,600 - $12,346
138 Added 8.18%
1,825 $156,000
Q3 2022

Nov 01, 2022

BUY
$59.54 - $68.01 $20,958 - $23,939
352 Added 26.37%
1,687 $104,000
Q2 2022

Jul 13, 2022

BUY
$57.72 - $65.01 $33,939 - $38,225
588 Added 78.71%
1,335 $82,000
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $32,666 - $40,935
-564 Reduced 43.02%
747 $45,000
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $13,040 - $14,801
-201 Reduced 13.29%
1,311 $95,000
Q3 2021

Oct 29, 2021

BUY
$67.69 - $73.03 $18,614 - $20,083
275 Added 22.23%
1,512 $106,000
Q2 2021

Aug 06, 2021

BUY
$63.47 - $69.35 $10,472 - $11,442
165 Added 15.39%
1,237 $85,000
Q1 2021

May 10, 2021

SELL
$60.0 - $68.46 $44,700 - $51,002
-745 Reduced 41.0%
1,072 $70,000
Q4 2020

Feb 09, 2021

SELL
$56.65 - $64.55 $27,135 - $30,919
-479 Reduced 20.86%
1,817 $106,000
Q3 2020

Nov 06, 2020

SELL
$62.1 - $78.08 $9,749 - $12,258
-157 Reduced 6.4%
2,296 $145,000
Q2 2020

Aug 10, 2020

SELL
$72.34 - $84.0 $6,438 - $7,476
-89 Reduced 3.5%
2,453 $188,000
Q1 2020

May 05, 2020

BUY
$62.63 - $80.22 $62,316 - $79,818
995 Added 64.32%
2,542 $190,000
Q4 2019

Jan 30, 2020

BUY
$61.62 - $67.78 $3,512 - $3,863
57 Added 3.83%
1,547 $100,000
Q3 2019

Nov 05, 2019

BUY
$62.51 - $69.0 $33,817 - $37,329
541 Added 57.01%
1,490 $94,000
Q2 2019

Aug 06, 2019

BUY
$61.87 - $69.38 $12,621 - $14,153
204 Added 27.38%
949 $64,000
Q1 2019

May 01, 2019

BUY
$62.53 - $70.05 $4,564 - $5,113
73 Added 10.86%
745 $48,000
Q4 2018

Jan 31, 2019

SELL
$60.54 - $79.0 $6,114 - $7,979
-101 Reduced 13.07%
672 $42,000
Q3 2018

Oct 12, 2018

SELL
$71.28 - $78.92 $570 - $631
-8 Reduced 1.02%
773 $60,000
Q2 2018

Aug 03, 2018

BUY
$64.88 - $75.68 $4,671 - $5,448
72 Added 10.16%
781 $55,000
Q1 2018

May 02, 2018

SELL
$72.84 - $88.8 $291 - $355
-4 Reduced 0.56%
709 $53,000
Q4 2017

Feb 05, 2018

BUY
$71.15 - $83.52 $13,233 - $15,534
186 Added 35.29%
713 $51,000
Q3 2017

Oct 27, 2017

BUY
$72.11 - $85.47 $38,001 - $45,042
527
527 $43,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.